{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:37:41Z","timestamp":1771663061047,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"DOI":"10.1007\/s10637-024-01496-2","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T21:50:59Z","timestamp":1735249859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deficiency of myeloid discoidin domain receptor 2 aggravates melanoma lung and bone metastasis"],"prefix":"10.1007","author":[{"given":"Yue","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangliang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoyang","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanhai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dageng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"1496_CR1","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1007\/s11864-023-01155-3","volume":"24","author":"WJ Sherman","year":"2023","unstructured":"Sherman WJ, Romiti E, Michaelides L, Moniz-Garcia D, Chaichana KL, Quinones-Hinojosa A, Porter AB (2023) Systemic therapy for melanoma brain and leptomeningeal metastases. Curr Treat Options Oncol 24:1962\u20131977","journal-title":"Curr Treat Options Oncol"},{"key":"1496_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/cancers12020482","volume":"12","author":"H Patel","year":"2020","unstructured":"Patel H, Yacoub N, Mishra R, White A, Yuan L, Alanazi S, Garrett JT (2020) Current advances in the treatment of BRAF-mutant melanoma. Cancers 12:482","journal-title":"Cancers"},{"key":"1496_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/ajd.14206","volume":"65","author":"R Sinclair","year":"2024","unstructured":"Sinclair R, Wong XL, Shumack S, Baker C, Macmahon B (2024) The role of micrometastasis in high-risk skin cancers. Australas J Dermatol 65:143\u2013152","journal-title":"Australas J Dermatol"},{"key":"1496_CR4","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.21037\/jtd.2020.03.120","volume":"13","author":"CY Bong","year":"2021","unstructured":"Bong CY, Smithers BM, Chua TC (2021) Pulmonary metastasectomy in the era of targeted therapy and immunotherapy. J Thorac Dis 13:2618\u20132627","journal-title":"J Thorac Dis"},{"key":"1496_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1200\/OP.21.00686","volume":"18","author":"B Switzer","year":"2022","unstructured":"Switzer B, Puzanov I, Skitzki JJ, Hamad L, Ernstoff MS (2022) Managing metastatic melanoma in 2022: a clinical review. JCO Oncol Pract 18:335\u2013351","journal-title":"JCO Oncol Pract"},{"key":"1496_CR6","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/cancers16101794","volume":"16","author":"G Cazzato","year":"2024","unstructured":"Cazzato G, Ingravallo G, Ribatti D (2024) Angiogenesis still plays a crucial role in human melanoma progression. Cancers 16:1794","journal-title":"Cancers"},{"key":"1496_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, Li J, Li F, Tan HB (2020) Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett 470:126\u2013133","journal-title":"Cancer Lett"},{"key":"1496_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2:e1600200","journal-title":"Sci Adv"},{"key":"1496_CR9","doi-asserted-by":"publisher","first-page":"16197","DOI":"10.3390\/ijms232416197","volume":"23","author":"A Gazzillo","year":"2022","unstructured":"Gazzillo A, Polidoro MA, Soldani C, Franceschini B, Lleo A, Donadon M (2022) Relationship between epithelial-to-mesenchymal transition and tumor-associated macrophages in colorectal liver metastases. Int J Mol Sci 23:16197","journal-title":"Int J Mol Sci"},{"key":"1496_CR10","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3390\/cancers12071888","volume":"12","author":"JE Olguin","year":"2020","unstructured":"Olguin JE, Medina-Andrade I, Rodriguez T, Rodriguez-Sosa M, Terrazas LI (2020) Relevance of regulatory T cells during colorectal cancer development. Cancers 12:1888","journal-title":"Cancers"},{"key":"1496_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.737674","volume":"12","author":"F Kong","year":"2021","unstructured":"Kong F, Chen T, Li X, Jia Y (2021) The current application and future prospects of Astragalus polysaccharide combined with cancer immunotherapy: a review. Front Pharmacol 12:737674","journal-title":"Front Pharmacol"},{"key":"1496_CR12","doi-asserted-by":"publisher","first-page":"44822","DOI":"10.1038\/srep44822","volume":"7","author":"L Zhou","year":"2017","unstructured":"Zhou L, Liu Z, Wang Z, Yu S, Long T, Zhou X, Bao Y (2017) Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo. Sci Rep 7:44822","journal-title":"Sci Rep"},{"key":"1496_CR13","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1074\/jbc.R112.444158","volume":"288","author":"HL Fu","year":"2013","unstructured":"Fu HL, Valiathan RR, Arkwright R, Sohail A, Mihai C, Kumarasiri M, Mahasenan KV, Mobashery S, Huang P, Agarwal G, Fridman R (2013) Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling. J Biol Chem 288:7430\u20137437","journal-title":"J Biol Chem"},{"key":"1496_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s10020-021-00388-y","volume":"27","author":"RA Hayuningtyas","year":"2021","unstructured":"Hayuningtyas RA, Han M, Choi S, Kwak MS, Park IH, Lee J-H, Choi JE, Kim DK, Son M, Shin JS (2021) The collagen structure of C1q induces wound healing by engaging discoidin domain receptor 2. Mol Med 27:125","journal-title":"Mol Med"},{"key":"1496_CR15","first-page":"163","volume":"27","author":"L Lugovic-Mihic","year":"2019","unstructured":"Lugovic-Mihic L, Cesic D, Vukovic P, Bilic GN, Situm M, Spoljar S (2019) Melanoma development: current knowledge on melanoma pathogenesis. Acta Dermatovenerol Croat 27:163\u2013168","journal-title":"Acta Dermatovenerol Croat"},{"key":"1496_CR16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/cas.14789","volume":"112","author":"Y Gao","year":"2021","unstructured":"Gao Y, Zhou J, Li J (2021) Discoidin domain receptors orchestrate cancer progression: a focus on cancer therapies. Cancer Sci 112:962\u2013969","journal-title":"Cancer Sci"},{"key":"1496_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.matbio.2023.12.003","volume":"125","author":"P Trono","year":"2024","unstructured":"Trono P, Ottavi F, Rosano L (2024) Novel insights into the role of discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention. Matrix Biol 125:31\u201339","journal-title":"Matrix Biol"},{"key":"1496_CR18","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1038\/s41388-022-02266-1","volume":"41","author":"M Sala","year":"2022","unstructured":"Sala M, Allain N, Moreau M, Jabouille A, Henriet E, Abou-Hammoud A, Uguen A, Di-Tommaso S, Dourthe C, Raymond AA et al (2022) Discoidin domain receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation. Oncogene 41:2571\u20132586","journal-title":"Oncogene"},{"key":"1496_CR19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/path.4311","volume":"232","author":"S Zhang","year":"2014","unstructured":"Zhang S, Bu X, Zhao H, Yu J, Wang Y, Li D, Zhu C, Zhu T, Ren T, Liu X et al (2014) A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis. J Pathol 232:436\u2013448","journal-title":"J Pathol"},{"key":"1496_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2024.06.013","volume":"150","author":"TA Klingen","year":"2024","unstructured":"Klingen TA, Chen Y, Aas H, Akslen LA (2024) DDR2 expression in breast cancer is associated with blood vessel invasion, basal-like tumors, tumor-associated macrophages, regulatory T cells, detection mode and prognosis. Hum Pathol 150:9\u201335","journal-title":"Hum Pathol"},{"key":"1496_CR21","doi-asserted-by":"publisher","first-page":"5169405","DOI":"10.1155\/2022\/5169405","volume":"2022","author":"I Romayor","year":"2022","unstructured":"Romayor I, Luque Garcia-Vaquero M, Marquez J, Arteta B, Barcelo R, Benedicto A (2022) Discoidin domain receptor 2 expression as worse prognostic marker in invasive breast cancer. Breast J 2022:5169405","journal-title":"Breast J"},{"key":"1496_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbrc.2023.01.074","volume":"649","author":"Q Liu","year":"2023","unstructured":"Liu Q, Wang X, Chen Y, Ma X, Kang X, He F, Feng D, Zhang Y (2023) Ablation of myeloid discoidin domain receptor 2 exacerbates arthritis and high fat diet induced inflammation. Biochem Biophys Res Commun 649:47\u201354","journal-title":"Biochem Biophys Res Commun"},{"key":"1496_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV et al (2018) An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173:400\u2013416","journal-title":"Cell"},{"key":"1496_CR24","unstructured":"Hothorn T. and Lausen B.(2002). Maximally selected rank statistics in R. Biometr J , 44."},{"key":"1496_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12935-020-1113-6","volume":"20","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Lin E, Zhuang H, Xie L, Feng X, Liu J, Yu Y (2020) Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma. Cancer Cell Int 20:27","journal-title":"Cancer Cell Int"},{"key":"1496_CR26","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3390\/cancers12071788","volume":"12","author":"J Wei","year":"2020","unstructured":"Wei J, Huang K, Chen Z, Hu M, Bai Y, Lin S, Du H (2020) Characterization of glycolysis-associated molecules in the tumor microenvironment revealed by pan-cancer tissues and lung cancer single cell data. Cancers 12:1788","journal-title":"Cancers"},{"key":"1496_CR27","doi-asserted-by":"publisher","first-page":"1903827","DOI":"10.1080\/21645515.2021.1903827","volume":"18","author":"L Tagliaferri","year":"2022","unstructured":"Tagliaferri L, Lancellotta V, Fionda B, Mangoni M, Casa C, Di Stefani A, Pagliara MM, D\u2019Aviero A, Schinzari G, Chiesa S et al (2022) Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review. Hum Vaccin Immunother 18:1903827","journal-title":"Hum Vaccin Immunother"},{"key":"1496_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"1496_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17\u201348","journal-title":"CA Cancer J Clin"},{"key":"1496_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","volume":"63","author":"C Garbe","year":"2016","unstructured":"Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Bastholt L, Grob J-J, Malvehy J, Newton-Bishop J, Stratigos AJ et al (2016) Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline \u2013 Update 2016. Eur J Cancer 63:201\u2013217","journal-title":"Eur J Cancer"},{"key":"1496_CR31","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M et al (2015) Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med 372:2521\u20132532","journal-title":"N Engl J Med"},{"key":"1496_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","volume":"41","author":"N Kumari","year":"2022","unstructured":"Kumari N, Choi SH (2022) Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies. J Exp Clin Cancer Res 41:68","journal-title":"J Exp Clin Cancer Res"},{"key":"1496_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z (2019) Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci 26:78","journal-title":"J Biomed Sci"},{"key":"1496_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s13402-019-00453-z","volume":"42","author":"A Salmaninejad","year":"2019","unstructured":"Salmaninejad A, Valilou SF, Soltani A, Ahmadi S, Abarghan YJ, Rosengren RJ, Sahebkar A (2019) Tumor-associated macrophages: role in cancer development and therapeutic implications. Cell Oncol 42:591\u2013608","journal-title":"Cell Oncol"},{"key":"1496_CR35","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1158\/2326-6066.CIR-13-0215","volume":"2","author":"ZA Cooper","year":"2014","unstructured":"Cooper ZA, Juneja VR, Sage PT, Frederick DT, Piris A, Mitra D, Lo JA, Hodi S, Freeman GJ, Bosenberg MW et al (2014) Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade. Cancer Immunol Res 2:643\u2013654","journal-title":"Cancer Immunol Res"},{"key":"1496_CR36","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1158\/1078-0432.CCR-11-1686","volume":"18","author":"K Valencia","year":"2012","unstructured":"Valencia K, Ormazabal C, Zandueta C, Luis-Ravelo D, Anton I, Pajares MJ, Agorreta J, Montuenga LM, Martinez-Canarias S, Leitinger B, Lecanda F (2012) Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis. Clin Cancer Res 18:969\u2013980","journal-title":"Clin Cancer Res"},{"key":"1496_CR37","doi-asserted-by":"publisher","first-page":"S245","DOI":"10.1016\/S0090-8258(21)01117-3","volume":"162","author":"E Stock","year":"2021","unstructured":"Stock E, Cho K, Lomonosova E, Schab A, Noia H, Bruce S, Khabele D, Kuroki L, Hagemann A, McCourt C et al (2021) Preventing ovarian cancer cell metastasis through inhibition of discoidin domain receptor 2 (DDR2) in the tumor microenvironment: a metabolomic analysis. Gynecol Oncol 162:S245","journal-title":"Gynecol Oncol"},{"key":"1496_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/abbs\/gmv005","volume":"47","author":"B Poudel","year":"2015","unstructured":"Poudel B, Lee YM, Kim DK (2015) DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2\/9 expression through ERK\/NF-\u03baB pathway. Acta Biochim Biophys Sin (Shanghai) 47:292\u2013298","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1496_CR39","first-page":"971","volume":"26","author":"I Badiola","year":"2011","unstructured":"Badiola I, Villace P, Basaldua I, Olaso E (2011) Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability. Oncol Rep 26:971\u2013978","journal-title":"Oncol Rep"},{"key":"1496_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000374054","volume":"36","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Su J, Teng Y, Zhang J, Wang J, Li K, Yao L, Li X (2015) Nrp1, a neuronal regulator, enhances DDR2-ERK-Runx2 cascade in osteoblast differentiation via suppression of DDR2 degradation. Cell Physiol Biochem 36:75\u201384","journal-title":"Cell Physiol Biochem"},{"key":"1496_CR41","doi-asserted-by":"publisher","first-page":"ra31","DOI":"10.1126\/scisignal.2005835","volume":"8","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Su J, Wu S, Teng Y, Yin Z, Guo Y, Li J, Li K, Yao L, Li X (2015) DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis. Sci Signaling. 8:ra31","journal-title":"Sci Signaling."},{"key":"1496_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.590941","volume":"10","author":"Z Ge","year":"2020","unstructured":"Ge Z, Ding S (2020) The crosstalk between tumor-associated macrophages (TAMs) and tumor cells and the corresponding targeted therapy. Front Oncol 10:590941","journal-title":"Front Oncol"},{"key":"1496_CR43","doi-asserted-by":"publisher","first-page":"10165","DOI":"10.18632\/aging.205858","volume":"16","author":"S Li","year":"2024","unstructured":"Li S, Sheng J, Zhang D, Qin H (2024) Targeting tumor-associated macrophages to reverse antitumor drug resistance. Aging 16:10165\u201310196","journal-title":"Aging"},{"key":"1496_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12974-022-02454-6","volume":"19","author":"Z Msheik","year":"2022","unstructured":"Msheik Z, El Massry M, Rovini A, Billet F, Desmouliere A (2022) The macrophage: a key player in the pathophysiology of peripheral neuropathies. J Neuroinflammation 19:97","journal-title":"J Neuroinflammation"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-024-01496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-024-01496-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-024-01496-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T23:02:02Z","timestamp":1735254122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-024-01496-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":44,"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1007\/s10637-024-01496-2","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}